+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Addiction Disorders Drugs Market by Indication, Product Type, Route Of Administration, Dosage Form, Distribution Channel, End User - Global Forecast to 2030- Product Image
Addiction Disorders Drugs Market by Indication, Product Type, Route Of Administration, Dosage Form, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Addiction Disorders Drugs Market by Indication, Product Type, Route Of Administration, Dosage Form, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 196 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5337785
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The addiction disorders drugs market is entering a pivotal phase as rising global prevalence and shifting treatment paradigms drive demand for targeted therapies and integrated approaches. Senior leaders in pharmaceutical, healthcare, and investment sectors require accurate, actionable insights to navigate its complexities, seize new opportunities, and anticipate coming challenges.

Market Snapshot: Addiction Disorders Drugs Market

The Addiction Disorders Drugs Market grew from USD 27.08 billion in 2024 to USD 28.89 billion in 2025. It is expected to continue growing at a CAGR of 6.48%, reaching USD 39.49 billion by 2030. This reporting period reflects increasing demand for pharmacological treatments across substance use conditions, bolstered by ongoing investment in personalized medicine, digital therapeutics, and regulatory innovations.

Scope & Segmentation

This research comprehensively addresses the current landscape and emerging dynamics within the addiction disorders drugs market. It offers a detailed analysis across key segments, regions, technologies, and stakeholder categories relevant to senior executives.

  • Therapeutic Indications: Alcohol dependence (acamprosate, disulfiram, naltrexone), opioid dependence (buprenorphine, methadone, naltrexone), smoking cessation (bupropion, varenicline, nicotine replacement therapies: gum, inhaler, lozenge, patch), stimulant dependence (off-label and research drugs)
  • Product Types: Branded and generic drug products covering a wide range of compound classes and therapy modalities
  • Routes of Administration: Oral, injectable (intramuscular and intravenous), sublingual (film, tablet), transdermal (patch)
  • Dosage Forms: Capsule, film, injectable solution, patch, tablet
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy
  • End Users: Clinics, homecare settings, hospitals
  • Regional Coverage: Americas (US—including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Pfizer Inc., Johnson & Johnson, Indivior plc, Alkermes plc, Camurus AB, Orexo AB, BioDelivery Sciences International Inc., Titan Pharmaceuticals Inc., Mallinckrodt plc, Teva Pharmaceutical Industries Ltd.

Key Takeaways

  • Shifts in regulatory environments and approvals are accelerating the entry of new opioid antagonists and long-acting formulations, enabling more precise patient management and facilitating value-based care models.
  • The adoption of digital health and telehealth integrations alongside pharmacologic therapies is transforming adherence monitoring and extending the reach of clinical support.
  • Societal and policy trends are reducing stigma, prompting earlier interventions, and increasing demand for therapies across socioeconomic groups.
  • Collaborations between payers, providers, and biopharma companies are advancing integrated and holistic approaches to addiction treatment, especially in response to evolving reimbursement models.
  • Competitive pressures from generics are driving cost efficiencies, broader accessibility, and pipeline diversification among established and emerging market participants.
  • Regional differences—in healthcare infrastructure and reimbursement—continue to shape therapy adoption rates, with developed regions favoring innovation and emerging markets prioritizing scalable, cost-efficient solutions.

Tariff Impact on Supply Chains

The introduction of US tariffs on active pharmaceutical ingredients and drug imports in 2025 has disrupted supply chains, especially for manufacturers reliant on external sources. To maintain price competitiveness, stakeholders are increasingly diversifying suppliers, exploring domestic production, and revising contract terms. The impact is most evident among generic and off-patent drug providers, whose profit margins are sensitive to production cost fluctuations. Agility in supply chain restructuring and strengthened operational resilience are serving as competitive differentiators in the evolving regulatory landscape.

Methodology & Data Sources

This report applies a multimodal research framework, integrating interviews with key opinion leaders, clinical trial registry analysis, and regulatory filings. Additional data points are drawn from peer-reviewed journals, industry white papers, and proprietary prescription and pricing databases. Validation is achieved through cross-referenced real-world utilization data and consultations with industry stakeholders and advisory panels.

Why This Report Matters

  • Informs strategic decision-making by providing senior leaders with actionable insights tied to evolving therapeutic, regulatory, and reimbursement trends in the addiction disorders drugs market.
  • Supports risk mitigation strategies by detailing supply chain responses and policy impacts relevant to current and future operations.
  • Empowers organizations to anticipate competitive moves, optimize portfolios, and identify promising avenues for investment and innovation.

Conclusion

The addiction disorders drugs market is undergoing transformative changes driven by innovation, policy reform, and shifting patient needs. Executives equipped with robust market intelligence can address challenges proactively and capitalize on new opportunities as the sector evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Addiction Disorders Drugs Market, by Indication
8.1. Introduction
8.2. Alcohol Dependence
8.2.1. Acamprosate
8.2.2. Disulfiram
8.2.3. Naltrexone
8.3. Opioid Dependence
8.3.1. Buprenorphine
8.3.2. Methadone
8.3.3. Naltrexone
8.4. Smoking Cessation
8.4.1. Bupropion
8.4.2. Nicotine Replacement Therapy
8.4.2.1. Gum
8.4.2.2. Inhaler
8.4.2.3. Lozenge
8.4.2.4. Patch
8.4.3. Varenicline
8.5. Stimulant Dependence
8.5.1. Off Label Drugs
8.5.2. Research Drugs
9. Addiction Disorders Drugs Market, by Product Type
9.1. Introduction
9.2. Branded
9.3. Generic
10. Addiction Disorders Drugs Market, by Route Of Administration
10.1. Introduction
10.2. Injectable
10.2.1. Intramuscular
10.2.2. Intravenous
10.3. Oral
10.4. Sublingual
10.4.1. Film
10.4.2. Tablet
10.5. Transdermal
10.5.1. Patch
11. Addiction Disorders Drugs Market, by Dosage Form
11.1. Introduction
11.2. Capsule
11.3. Film
11.4. Injectable Solution
11.5. Patch
11.6. Tablet
12. Addiction Disorders Drugs Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Addiction Disorders Drugs Market, by End User
13.1. Introduction
13.2. Clinics
13.3. Homecare Settings
13.4. Hospitals
14. Americas Addiction Disorders Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Addiction Disorders Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Addiction Disorders Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Johnson & Johnson
17.3.3. Indivior plc
17.3.4. Alkermes plc
17.3.5. Camurus AB
17.3.6. Orexo AB
17.3.7. BioDelivery Sciences International, Inc.
17.3.8. Titan Pharmaceuticals, Inc.
17.3.9. Mallinckrodt plc
17.3.10. Teva Pharmaceutical Industries Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. ADDICTION DISORDERS DRUGS MARKET MULTI-CURRENCY
FIGURE 2. ADDICTION DISORDERS DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. ADDICTION DISORDERS DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. ADDICTION DISORDERS DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. ADDICTION DISORDERS DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ADDICTION DISORDERS DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ACAMPROSATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISULFIRAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPRENORPHINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY METHADONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NALTREXONE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BUPROPION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INHALER, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY LOZENGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY VARENICLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OFF LABEL DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY RESEARCH DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY FILM, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PATCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ADDICTION DISORDERS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 91. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 93. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 94. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 95. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 96. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 97. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 98. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 100. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 101. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 102. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 103. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. CANADA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 106. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 107. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 108. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 109. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 110. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 111. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 113. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 114. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 115. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 116. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 117. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 118. MEXICO ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 128. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 129. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 135. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 136. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 137. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 138. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 139. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 140. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 141. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 142. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 143. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 144. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 145. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. ARGENTINA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 162. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 164. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 166. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 168. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 170. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 172. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 177. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 178. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 179. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 180. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 181. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 182. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 185. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 186. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 187. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 188. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 189. GERMANY ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 192. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 193. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 194. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 195. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 196. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 199. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 200. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 201. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 202. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. FRANCE ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 205. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 206. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 207. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 208. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 209. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 210. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 211. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 212. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 213. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 214. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 215. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 216. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 217. RUSSIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 218. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 219. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 220. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 221. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 222. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 223. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 224. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 225. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 226. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 227. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 228. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 229. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 230. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. ITALY ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 233. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 234. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 235. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 236. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 237. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 238. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 241. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 242. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 243. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 244. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. SPAIN ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 262. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 264. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 266. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 282. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 284. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 286. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 289. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 290. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 291. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 292. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 293. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 294. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 295. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 296. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 297. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 298. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 299. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 300. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. DENMARK ADDICTION DISORDERS DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 303. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ALCOHOL DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 304. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY OPIOID DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 305. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY SMOKING CESSATION, 2018-2030 (USD MILLION)
TABLE 306. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY NICOTINE REPLACEMENT THERAPY, 2018-2030 (USD MILLION)
TABLE 307. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY STIMULANT DEPENDENCE, 2018-2030 (USD MILLION)
TABLE 308. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 309. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 310. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 311. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY SUBLINGUAL, 2018-2030 (USD MILLION)
TABLE 312. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY TRANSDERMAL, 2018-2030 (USD MILLION)
TABLE 313. NETHERLANDS ADDICTION DISORDERS DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Addiction Disorders Drugs market report include:
  • Pfizer Inc.
  • Johnson & Johnson
  • Indivior plc
  • Alkermes plc
  • Camurus AB
  • Orexo AB
  • BioDelivery Sciences International, Inc.
  • Titan Pharmaceuticals, Inc.
  • Mallinckrodt plc
  • Teva Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages196
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 28.89 Billion
Forecasted Market Value ( USD ) by 2030 $ 39.49 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Addiction Therapeutics - Global Strategic Business Report - Product Image

Addiction Therapeutics - Global Strategic Business Report

  • Report
  • 281 Pages
  • Global
From
Smoking Cessation & Nicotine De-Addiction Product Market by Product Type, Route Of Administration, Distribution Channel, End User, Nicotine Strength, Age Group - Global Forecast to 2030 - Product Image

Smoking Cessation & Nicotine De-Addiction Product Market by Product Type, Route Of Administration, Distribution Channel, End User, Nicotine Strength, Age Group - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Substance Abuse and Addiction Treatment Market Report 2025 - Product Image

Substance Abuse and Addiction Treatment Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Addictions Therapeutics Market Report 2025 - Product Image

Addictions Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Addiction Treatment - Global Strategic Business Report - Product Image

Addiction Treatment - Global Strategic Business Report

  • Report
  • 242 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.